Valeo Pharma Inc (VPH.CX)

0.96 -0.02  -2.04% CNSX Jun 18, 20:00 CAD

Ratings & Reports



  • Description: Valeo Pharma Inc a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its products include Benztropine, Synacthen, M-Eslon, and among others.
  • URL:
  • Investor Relations URL: N/A
  • HQ State/Province: Quebec
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: N/A
  • Last Earnings Release: N/A
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.